Home  

>>日本語


AyoxxA is a Biotechnology company led by Dr Andreas Schmidt (CEO) and Prof Dieter Trau (CSO). Michael Rasche, Corporate Vice President Global Commercial Operations and Dr. Markus Zumbansen, VP Research and Development complete the leadership team.
>>
 
AyoxxA has established corporate headquarters in Cologne, Germany in Spring 2012 and continues to run operations in Singapore. AyoxxA has also closed Series A round of finance.
>>
 
Detection of analytes on our chip is based on a fluorescent signal. These signals can be detected by a microscope or many different automated readers.
>>
 
AyoxxA Biosystems Closes Series A Financing Round.
3 Million Euro financing will accelerate development of cutting-edge technology for protein analysis.
>>